Winter 2024 Investor Summit Virtual

40 MicroCap Presenters – November 21, 2024

9:00am-4:00pm ET – Company Presentations
8:00am-4:00pm – 1×1 Meetings

Q4 Presenters

...
TNXP

  • Tonix submitted a New Drug Application to the FDA in October 2024.
  • An FDA decision on the NDA is expected in 2025, with potential product launch in 2025 if approved.
...
URG

  • Largest U.S. uranium miner
  • Nuclear energy sector is in rapid growth
...
TMGEF

  • Proprietary energy efficiency solutions provide high ROI
  • Track record of profitable growth with significant repeat business from F500
...
TGCB

  • Product, people, plan, opportunity = success
  • Commercial success is in process
...
MFIN

  • MFIN has a proven track record of growing loan portfolio.
  • Above average NIM gives flexibility and options.
...
NMTC

  • Thin-film electrode platform technology with multiple market opportunities treating and diagnosing neurological disorders and pain.
  • Improving financial profile. Now have 3 product families commercialized in the United States.
...
NRBO

  • Targeting Obesity and MASH with a Pipeline of Next Generation Therapeutics
  • Aiming to increase Shareholder Value through Multiple, Near-Term, Value Creating Milestones DA-1726
...
IMUX

  • Immunic is developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases
  • Top-line data from the phase 2 CALLIPER trial of vidofludimus calcium in PMS is expected in April 2025
...
SOTK

  • Consistently profitable with strong growth trajectory in disruptive high tech markets.
  • Record revenue in Fiscal year 2024, 30% YOY growth.
...
ACFN

  • Liquidity of the shares will improve with performance and as the price increases towards intrinsic value.
  • Acorn's results are just starting to reflect a large contract with a leading Telecom provider.
...
OESX

  • FY’25 revenue expected to increase 10% weighted toward the 2H.
  • EV charging grew 40% in Q2; $7.5B of Federal funding appropriated for EV infrastructure.
...
FET

  • Increasing global energy demand will propel long-term investment
  • Global footprint and strategy execution will drive strong free cash flow
...
BENF

  • Innovative access to private equity investments via public equity stock
  • Transitioned to GAAP net income profitable operations in F1Q 2025 (June 30 Quarter End)
...
IMRN

  • September 2024 Quarter AUD$1.5 million up 13% on prior quarter
  • Sales of Travelan® increased 3% to AUD $1.007 million during September 2024 Quarter
...
ACON

  • Industry 1st noninvasive diagnostic with strong clinical evidence of value
  • Nearly 60% of all patients with private health insurance in the greater London market now have Access to Aclarion’s Nociscan
...
AUUD

  • Leading the audio superapp space with differentiation & margin
  • Accretive M&A strategy to accelerate revenue & user acquisitions
...
SNGX

  • Robust pipeline with multiple fast track and/or orphan designated products, potential for significant commercial returns
  • Late clinical-stage assets, one with successful Phase 3 data readout
...
CPSH

  • Unique applications in rapidly-expanding markets
  • Strong balance sheet
  • New contract wins
  • At inflection point for growth
...
ASNS

  • Actelis is growing as the results of the year to-date can attest to, showing nearly 50% growth year over year, gross margin grew and net loss/EBITDA shrunk dramatically.
  • The company is expanding its reach into several segments such as cyber security of IoT devices in roads, cities, and more as well as multi-dwelling units
...
PERF

  • Industry growth potential in beauty/fashion tech
  • PERF's strength and innovations for growth in B2B (SAAS) and B2C (suite of apps under YouCam brand).
...
ULY

  • Leading proprietary digitally native mobility services platform
  • Uniquely positioned to further penetrate $25B B2B incident business opportunity
...
PLUR

  • $10m raise in EverAfter Foods from Global Food Giants as Strategic Partners
  • Innovative collaborations with multi-national agriculture corporations - €1 million POC project
...
SPGC

  • 3Q24 revenue +1163% YOY and +48% QoQ
  • Newton Motion replacement shafts is company's key product line and is showing significant growth and even gaining traction with professional golfers.
...
HLRTF

  • A clean technology company developing high value, high performance power conversion
  • Technologies for next-generation powertrains and grid-connected renewable energy systems

The Speakers

Lavall Chichester

Founder CEO, Growth Skills

Greg Falesnik

CEO, MZ North America

Fred Rockwell

Founder CEO, Ascent

Jordan Darrow

Founder & CEO, Darrow
Associates

Valter Pinto

Managing Director, KCSA
Strategic Communications

Dr. John Roy

Managing Director - Technology Equity
Research, Water Tower Research LLC

Chuck Bennett

CEO & Founder, CorelR Public
& Investor Relations

Kirin Smith

President, PCG Advisory Group

Nate Tobik

CEO, CompleteBankData

Curtis Shauger

Managing Director, Water
Tower Research LLC

Andrew Shapiro

President & Portfolio Manager,
Lawndale Capital Management

Destiny Hance

Vice President, Equity Research,
Ladenburg Thalmann

Paul Antico

Founder and Portfolio Manager,
Sandy Cove Investments

Yaky Yanay

CEO and President,
Pluri Inc.

Connecting Microcap Companies with Leading Investors

Why We Are Better

GATED AND VETTED

0 deal guys and 0 service providers

ACTUAL RESULTS

8 truly qualified meetings per company

37 presentation views + thousands of newsletter impressions post event

CONCIERGE SERVICE

The experience is a light lift for the presenting companies. Our investors show up and come prepared.

INTENT

At vendor events, meetings are often favors. Meetings with us are a result of true intent to buy on the open market.

WE ARE INDEPENDENT

We only focus on providing companies with high quality service and do not sell anything else after the event.

Virtual Event Format

70 Presentations From the Fastest Growing Micro-Cap Companies
30 Live Due Diligence Sessions, where investing experts drive the convo
400 1x1s and 3x1s meetings with management 
Find your next 10-Bagger 
Get a glimpse of what your peers are thinking 

Sponsors

Who Participates

Market Cap

 $0 – $50M (37%)
 
$50 – $100M (41%)
 
$100 – $300 (13%)
 
$300+ (9%)

Sector

 Healthcare (25%)
 
Consumer/Financial (23%)
 
Technology (22%)
 
Energy/Cannabis (16%)
 
Industrial/Blockchain (14%)

Investor Breakdown

 Family Office (12%)
 
Institutional (61%)
 
HNW (9%)
 
RIAs (18%)

Request a Meeting

Request Meeting